UNICA IRIS Institutional Research Information System

CARBONI, EZIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 161.313
NA - Nord America 10.036
AS - Asia 3.900
SA - Sud America 658
Continente sconosciuto - Info sul continente non disponibili 212
AF - Africa 89
OC - Oceania 32
Totale 176.240
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 158.554
US - Stati Uniti d'America 9.868
CN - Cina 1.476
SG - Singapore 1.439
UA - Ucraina 733
DE - Germania 544
BR - Brasile 522
SE - Svezia 452
FI - Finlandia 312
VN - Vietnam 271
GB - Regno Unito 241
FR - Francia 209
HK - Hong Kong 153
KR - Corea 100
CA - Canada 86
IN - India 82
RU - Federazione Russa 79
BD - Bangladesh 77
AR - Argentina 56
JP - Giappone 52
NL - Olanda 47
MX - Messico 37
TR - Turchia 29
AU - Australia 26
PL - Polonia 26
IE - Irlanda 25
IQ - Iraq 24
CL - Cile 20
ES - Italia 20
PK - Pakistan 20
ZA - Sudafrica 19
CO - Colombia 17
IR - Iran 17
ID - Indonesia 16
UZ - Uzbekistan 16
TH - Thailandia 15
AT - Austria 14
EC - Ecuador 13
EG - Egitto 13
IL - Israele 13
MA - Marocco 13
PH - Filippine 13
BE - Belgio 12
VE - Venezuela 12
JM - Giamaica 10
SA - Arabia Saudita 10
EU - Europa 9
GH - Ghana 9
KE - Kenya 9
MY - Malesia 9
CY - Cipro 8
OM - Oman 8
TW - Taiwan 8
CZ - Repubblica Ceca 7
BO - Bolivia 6
HN - Honduras 6
LB - Libano 6
NP - Nepal 6
NZ - Nuova Zelanda 6
TT - Trinidad e Tobago 6
AE - Emirati Arabi Uniti 5
AZ - Azerbaigian 5
GR - Grecia 5
JO - Giordania 5
KZ - Kazakistan 5
PY - Paraguay 5
TN - Tunisia 5
UY - Uruguay 5
CR - Costa Rica 4
DZ - Algeria 4
ET - Etiopia 4
LT - Lituania 4
RO - Romania 4
AL - Albania 3
CH - Svizzera 3
DO - Repubblica Dominicana 3
KW - Kuwait 3
MU - Mauritius 3
PA - Panama 3
BY - Bielorussia 2
CI - Costa d'Avorio 2
GT - Guatemala 2
HU - Ungheria 2
LC - Santa Lucia 2
LU - Lussemburgo 2
MK - Macedonia 2
NI - Nicaragua 2
PE - Perù 2
PT - Portogallo 2
SK - Slovacchia (Repubblica Slovacca) 2
SV - El Salvador 2
AO - Angola 1
BB - Barbados 1
BG - Bulgaria 1
BS - Bahamas 1
BW - Botswana 1
CG - Congo 1
DK - Danimarca 1
GA - Gabon 1
GN - Guinea 1
Totale 176.017
Salva come PNG Salva come JPEG
Città #
Cagliari 154.879
Uta 3.203
Fairfield 879
Woodbridge 871
Ashburn 780
Singapore 722
San Jose 584
Chandler 565
Houston 485
Boardman 411
Jacksonville 408
Ann Arbor 404
Wilmington 392
Seattle 382
Dallas 346
Nyköping 280
Cambridge 277
Dearborn 252
Beijing 232
Helsinki 188
Council Bluffs 155
Los Angeles 154
Santa Clara 134
Hefei 126
Nanjing 119
Hong Kong 116
Lauterbourg 104
Boston 100
The Dalles 100
Shanghai 89
Ho Chi Minh City 88
Seoul 86
New York 83
Guangzhou 74
Buffalo 68
Hanoi 66
Milan 57
San Diego 47
Shenyang 45
Redwood City 40
São Paulo 39
Hebei 38
Toronto 37
Chicago 32
Frankfurt am Main 32
Nanchang 32
Orem 32
Tokyo 32
Jiaxing 29
Mountain View 28
Tianjin 27
Atlanta 26
Jinan 25
Changsha 24
Washington 24
Brooklyn 22
Dublin 22
Munich 22
San Francisco 22
Amsterdam 21
Norwalk 21
Columbus 20
London 20
Verona 19
Zhengzhou 19
Rome 18
Redondo Beach 17
Assèmini 16
Montreal 16
Phoenix 16
Dhaka 15
Tashkent 15
Augusta 14
Cleveland 14
Da Nang 14
Orange 14
Turku 14
Auburn Hills 13
Denver 13
San Mateo 13
Brussels 12
Rio de Janeiro 12
Belo Horizonte 11
Ningbo 11
Pune 11
Warsaw 11
Detroit 10
Haiphong 10
Kunming 10
Wuhan 10
Accra 9
Charlotte 9
Chennai 9
Mexico City 9
Miami 9
Mumbai 9
Pittsburgh 9
Baghdad 8
Brisbane 8
Bristol 8
Totale 169.473
Salva come PNG Salva come JPEG
Nome #
Key role of salsolinol in ethanol actions on dopamine neuronal activity of the posterior ventral tegmental area 5.448
Differential sensitivity of ethanol-elicited ERK phosphorylation in nucleus accumbens of Sardinian alcohol-preferring and -non preferring rats 4.176
null 4.110
Immunization with DISC1 protein in an animal model of ADHD influences behavior and excitatory amino acids in prefrontal cortex and striatum 3.658
The MPTP/probenecid model of progressive Parkinson's disease 3.538
Increase of dopamine and norepinephrine release in the bed nucleus of stria terminalis: a common feature of antidepressants? 3.509
Immunomodulatory drugs alleviate l-dopa-induced dyskinesia in a rat model of Parkinson's disease 3.471
Rosiglitazone decreases peroxisome proliferator receptor-gamma levels in microglia and inhibits TNF-alpha production: new evidences on neuroprotection in a progressive Parkinson's disease model. 3.269
PPAR-gamma agonist rosiglitazone inhibits TNF-alpha production by microglia and arrests nigrostriatal degeneration in a progressive Parkinson’s disease model. 3.193
A442 PPAR-gamma agonist rosiglitazone inhibits TNF-alpha production by microglia and arrests neurodegeneration in a progressive Parkinson´s disease model 3.041
Do PPAR-Gamma Agonists Have a Future in Parkinson's Disease Therapy? 2.866
PRENATAL RESTRAINT STRESS: AN IN VIVO MICRODIALYSIS STUDY ON CATECHOLAMINE RELEASE IN THE RAT PREFRONTAL CORTEX 2.824
52) Carboni E., Ibba M., Schirru C., Sadile A. (2009). BEHAVIORAL AND NEUROCHEMICAL CHANGES INDUCED BY METHYLPHENIDATE OR ATOMOXETINE SUB-CHRONIC TREATMENT IN ADOLESCENT SPONTANEOUS HYPERTENSIVE RATS (SHR) ARE GENDER SPECIFIC 2.740
Long term effects of adolescent chronic mild stress on brain catecholamine transmission in rat brain: a microdialysis study 2.663
Antidepressants share the ability to increase catecholamine output in the bed nucleus of stria terminalis: a possible role in antidepressant therapy? 2.603
null 2.592
Different classes of antidepressants increase dopamine and norepinephrine release in the bed nucleus of stria terminalis: an “in vivo” microdialysis study 2.563
The alpha 7 nicotinic acetylcholine receptor (nAChR) allosteric modulator UCI-40083 differentially increases dopamine (DA) and norepinephrine (NE) release in adolescent rat brain 2.561
Prepuberal Stimulation of 5-HT7-R by LP-211 in a Rat Model of Hyper-Activity and Attention-Deficit: Permanent Effects on Attention, Brain Amino Acids and Synaptic Markers in the Fronto-Striatal Interface 2.560
Disease modifying treatment with PPAR-gamma agonist rosiglitazone in a progressive mouse model of Parkinson's disease 2.511
The α7 nicotinic acetylcholine receptor (nAChR) allosteric modulator UCI-40083 differentially increases dopamine (DA) and norepinephrine (NE) release in adolescent rat brain 2.480
Progressive Dopaminergic Degeneration in the Chronic MPTPp Mouse Model of Parkinson's Disease 2.433
Nicotine, cocaine, amphetamine, morphine, and ethanol increase norepinephrine output in the bed nucleus of stria terminalis of freely moving rats 2.299
Ketamine modulates catecholamine transmission in the bed nucleus of stria terminalis: The possible role of this region in the antidepressant effects of ketamine 2.258
PPAR-gamma-mediated neuroprotection in a chronic mouse model of Parkinson's disease 2.247
Different classes of antidepressants share the ability to increase dopamine and norepinephrine release in the bed nucleus of stria terminalis: A possible role in antidepressant therapy? 2.186
null 2.160
PPAR-GAMMA RECEPTOR AGONIST PREVENTS NEURODEGENERATION AND BEHAVIOURAL DEFICITS IN A CHRONIC MPTP MOUSE MODEL OF PARKINSON’S DISEASE. 2.108
Chronic methylphenidate or atomoxetine treatment alters BDNF expression in the brain of spontaneously hypertensive rats 2.105
The interrelationship between dopamine and noradrenaline in the prefrontal cortex: From physiology to therapy 2.026
Drug induced release of dopamine and noradrenaline in the forebrain of the prenatally stressed rats 2.024
(D-Ala2)deltorphin II: D1-dependent stereotypies and stimulation of dopamine release in the nucleus accumbens 2.005
PROGRESSIVE DECLINE OF BEHAVIORAL AND BIOCHEMICAL PARAMETERS IN THE CHRONIC MPTP/PROBENECID MOUSE MODEL OF PARKINSON’S DISEASE. 1.960
METHYLPHENIDATE AND ATOMOXETINE AFFECT BDNF EXPRESSION IN THE BRAIN OF SPONTANEOUS HYPERTENSIVE RATS. 1.890
PEROXIZOME-PROLIFERATOR ACTIVATED RECEPTOR GAMMA (PPARG) AGONIST ROSIGLITAZONE COUNTERACTS BEHAVIORAL AND BIOCHEMICAL DEFICITS IN A CHRONIC 1-METHYL-4-PHENIL-1,2,3,4 TETRAHYDROPYRIDINE (MPTP) MOUSE MODEL OF PARKINSON’S DISEASE 1.888
Sub-chronic exposure to atomoxetine up-regulates BDNF expression and signalling in the brain of adolescent spontaneously hypertensive rats: comparison with methylphenidate. 1.793
Advances in modelling alpha-synuclein-induced Parkinson's diseases in rodents: virus-based models versus inoculation of exogenous preformed toxic species 1.790
Enhanced limbic/impaired cortical-loop connection onto the hippocampus of NHE rats: Application of resting-state functional connectivity in a preclinical ADHD model 1.777
Effects of sub-chronic methylphenidate and atomoxetine on noradrenaline and dopamine transmission in the prefrontal cortex of adolescent SH rats, an animal model of ADHD 1.737
Prepuberal subchronic methylphenidate and atomoxetine induce different long-term effects on adult behaviour and forebrain dopamine, norepinephrine and serotonin in Naples high-excitability rats 1.681
Repurposing Pomalidomide as a Neuroprotective Drug: Efficacy in an Alpha-Synuclein-Based Model of Parkinson's Disease 1.649
Galactosilated dopamine increases attention without reducing activity in C57BL/6 mice 1.645
Prenatal restraint stress differentially modifies basal and stimulated dopamine and noradrenaline release in the nucleus accumbens shell: an 'in vivo' microdialysis study in adolescent and young adult rats. 1.549
CAFFEINE AND ACCUMBENS SHELL DOPAMINE 1.529
Gender specific reduction of hypermotility by sub-chronic methylphenidate or atomoxetine in SH rats, an animal model of ADHD 1.455
PREPUBERAL SUBCHRONIC METHYLPHENIDATE AND ATOMOXETINE INDUCE DIFFERENTIAL LONG TERM EFFECTS ON ADULT BEHAVIOR AND FOREBRAIN DOPAMINE, NOREPINEPHRINE AND SEROTONIN IN NAPLES HIGH EXCITABILITY RATS 1.409
Can pioglitazone be potentially useful therapeutically in treating patients with Covid-19? 1.405
DIFFERENT EFFECTS OF METHYLPHENIDATE AND ATOMOXETINE ON BDNF EXPRESSION IN THE BRAIN OF SPONTANEOULSY HYPERTENSIVE RATS 1.361
Galactosylated dopamine enters into the brain, blocks the mesocorticolimbic system and modulates activity and scanning time in Naples high excitability rats. 1.347
Stimulation of in vivo dopamine transmission in the bed nucleus of stria terminalis by reinforcing drugs 1.292
Cumulative effect of norepinephrine and dopamine carrier blockade on extracellular dopamine increase in the nucleus accumbens shell, bed nucleus of stria terminalis and prefrontal cortex 1.258
CHRONIC TREATMENT WITH METHYLPHENIDATE OR ATOMOXETINE DETERMINES CHANGES OF NORADRENARGIC AND DOPAMINERGIC TRANSMISSION IN THE PREFRONTAL CORTEX OF ADOLESCENT SPONTANEOUS HYPERTENSIVE RATS (SHR): A MICRODIALYSIS STUDY. 1.225
DOPAMINERGIC NEUROTRANSMISSION IN A RAT MODEL OF PRENATAL STRESS 1.170
Function of dopamine in the extrapyramidal and limbic systems 1.133
42) Carboni E, Silvagni A, Barros VG, Di Chiara G. (2006). BASAL AND AMPHETAMINE STIMULATED DOPAMINE AND NORADRENALINE TRANSMISSION IN RAT BRAIN ARE DIFFERENTIALLY AFFECTED BY PRENATAL STRESS: AN IN VIVO MICRODIALYSIS STUDY. 1.127
INCREASE OF EXTRACELLULAR DOPAMINE IN THE PREFRONTAL CORTEX - A TRAIT OF DRUGS WITH ANTIDEPRESSANT POTENTIAL 1.124
BDNF Alterations in Brain Areas and the Neurocircuitry Involved in the Antidepressant Effects of Ketamine in Animal Models, Suggest the Existence of a Primary Circuit of Depression 1.114
Similarities and differences between nicotine and food reward relevance for a theory of reward. 1.043
The Intranigral Infusion of Human-Alpha Synuclein Oligomers Induces a Cognitive Impairment in Rats Associated with Changes in Neuronal Firing and Neuroinflammation in the Anterior Cingulate Cortex 1.042
Homologies and differences in the action of drugs of abuse and a conventional reinforcer (food) on dopamine transmission: an interpretative framework of the mechanism of drug dependence. 1.035
Antidepressants, dose dependently, increase dopamine and norepinephrine extracellular concentration in rat bed nucleus of stria terminalis: a microdialysis study 999
A microdyalisis study of dopamine transmission in the nucleus accumbens shell of SHR rats: a model of attention deficit hyperactivity disorder (ADHD) 985
A MICRODIALYSIS STUDY OF DOPAMINE TRANSMISSION IN THE NUCLEUS ACCUMBENS SHELL OF SHR RATS: A MODEL OF ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD) 946
Stimulation of Dopamine Release in the Bed Nucleus of Stria Terminalis. A Trait of Atypical Antipsychotics? 900
Naples high excitability and spontaneously hypertensive model different variants of attention-deficit hyperactivity disorder 894
Dissociation of physical abstinence signs from changes in extracellular dopamine in the nucleus accumbens and in the prefrontal cortex of nicotine dependent rats 850
Differential induction of dyskinesia and neuroinflammation by pulsatile versus continuous L-DOPA delivery in the 6-OHDA model of Parkinson's disease 845
A challenge dose of amphetamine can be used as a tollo for assessing changes in dopamine and noradrenaline transmission induced by prenatal stress in rats 819
Increase of dialysate dopamine in the bed nucleus of stria terminalis by clozapine and related neuroleptics 817
Effect of amphetamine, cocaine and experimental Investigation on dopamine trasmission can provide clues on the mechanism of action of amphetamine and methylphenidate in ADHD 786
Detection of 3H-cimetidine specific binding in rat anterior pituitary 780
Effect of Dopamine and Norepinephrine Carrier Blockade on Extracellular Dopamine Release in Rat Brain 773
Effect of amphetamine, cocaine and depolarization by high potassium on extracellular dopamine in the nucleus accumbens shell of SHR rats. An in vivo microdyalisis study 768
6-Hydroxydopamine lesions reduce specific [3H]sulpiride binding in the rat substantia nigra: direct evidence for the existence of nigral D-2 autoreceptors 768
Experimental investigations on dopamine transmission can provide clues on the mechanism of the therapeutic effect of amphetamine and methylphenidate in ADHD. 757
Role of prefrontal cortex dopamine and noradrenaline circuitry in addiction 751
Dopamine reuptake by norepinephrine neurons: exception or rule? 736
5HT3 antagonists specifically block morphine and nicotine reward 714
Dopamine and drug addiction: the nucleus accumbens shell connection 711
Stimulation of dopamine transmission in the dorsal caudate nucleus by pargyline as demonstrated by dopamine and acetylcholine microdialysis and fos immunohistochemistry 703
Repurposing Ketamine in Depression and Related Disorders: Can This Enigmatic Drug Achieve Success? 695
EFFECT OF PRENATAL STRESS ON BASAL AND STIMULATED DOPAMINE AND NORADRENALINE TRANSMISSION IN RAT BRAIN: IN VIVO MICRODIALYSIS STUDY. 681
Ethanol: lack of stimulation of chloride influì in rat brain synaptoneurosomes 665
CONDITIONED PLACE PREFERENCE: A SIMPLE METHOD FOR INVESTIGATING REINFORCING PROPERTIES IN LABORATORY ANIMALS 658
Dihydropyridines change the uptake of calcium induced by depolarization into primary cultures of cerebellar granule cells. 653
Characterization of stereospecific binding of 3H-(-) sulpiride, a selective antagonist at dopamine-D2 receptors, in rat CNS. 645
COMBINED MICRODIALYSIS AND FOS IMMUNOHISTOCHEMISTRY FOR THE ESTIMATION OF DOPAMINE NEUROTRANSMISSION IN THE RAT CAUDATE-PUTAMEN 640
null 638
Serotonin release and metabolism in rat cortex as studied by transcerebral dialysis. 637
null 637
null 622
null 617
Characterization of peripheral benzodiazepine type sites in a cultured murine BV-2 microglial cell line 609
SCH 23390 antagonizes apomorphine- and ergot-induced hypothermia. 608
Dihydropyridine binding sites regulate calcium influx through specific voltage-sensitive calcium channels in cerebellar granule cells. 589
null 586
null 583
null 580
Dopamine inhibition of neurotensin-induced increase in Ca2+ influx into rat pituitary cells. 569
null 568
Totale 159.437
Salva come PNG Salva come JPEG
Categoria #
all - tutte 227.043
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 227.043
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20226.322 0 0 746 362 481 509 647 489 475 877 717 1.019
2022/202313.596 1.072 1.834 1.208 1.046 1.177 1.179 758 1.094 1.032 1.178 1.395 623
2023/202413.893 606 612 734 830 1.398 2.199 2.279 1.067 631 1.059 1.092 1.386
2024/202530.084 8.438 9.025 4.070 2.666 1.594 1.630 1.320 191 282 272 292 304
2025/20267.704 362 308 918 534 515 911 1.202 508 567 1.168 508 203
2026/20271.179 176 640 363 0 0 0 0 0 0 0 0 0
Totale 176.240